Home > Clinical Trials

Saved trials

RECRUITING
NCT06467357
Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer
620 Enrollment(s)
270 Study location(s)
INTERVENTIONAL (PHASE3)
Biliary Tract Cancer
RECRUITING
NCT05417594
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
695 Enrollment(s)
32 Study location(s)
INTERVENTIONAL (PHASE1|||PHASE2)
Advanced Solid Malignancies
NOT_YET_RECRUITING
NCT07683754
T-DXd Based Therapy Followed by Endocrine Therapy Plus Dual HER2 Blockade in First-line HER2+/ HR+ Metastatic Breast Cancer and Retreatment With T-DXd
200 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE3)
Advanced Breast Cancer


Metastatic Breast Cancer


HER2 Positive


HR Positive
RECRUITING
NCT06899126
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
686 Enrollment(s)
160 Study location(s)
INTERVENTIONAL (PHASE3)
Non-small Cell Lung Cancer
ACTIVE_NOT_RECRUITING
NCT06578247
Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML
700 Enrollment(s)
284 Study location(s)
INTERVENTIONAL (PHASE3)
Leukemia
RECRUITING
NCT05491200
Comparison Of Reduced DAPT Followed by P2Y12 Inhibitor Monotherapy With Prasugrel vs stAndard Regimen in STEMI Patients
1,656 Enrollment(s)
27 Study location(s)
INTERVENTIONAL (PHASE4)
ST Elevated Myocardial Infarction


Dual Antiplatelet Therapy
ACTIVE_NOT_RECRUITING
NCT03127631
A Study for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients
5,000 Enrollment(s)
61 Study location(s)
INTERVENTIONAL (NA)
Prostate Cancer


Cardiovascular Disease
NOT_YET_RECRUITING
NCT07678957
A Study Comparing BL-M07D1 With DS-8201 in Patients With HR-Positive, HER2-Low Expressing Recurrent/Metastatic Breast Cancer
120 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2)
Breast Cancer